Rheumatologic disease with peripheral eosinophilia

Rheumatology International

Volumn 24, Issue 6, 2004, Pages 317-320

  Bavbek, Nüket ^a   Kargılı, Ayşe ^a   Cipil, Handan ^a   Koşar, Ali ^a   Karaaslan, Yaşar ^a  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

Author keywords

Connective tissue diseases; Eosinophilia; Rheumatologic diseases

Indexed keywords

ALLOPURINOL; BUCILLAMINE; CORTICOSTEROID; METHOTREXATE; PENICILLAMINE;

BUERGER DISEASE; CHURG STRAUSS SYNDROME; COMORBIDITY; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EOSINOPHILIA MYALGIA SYNDROME; EOSINOPHILIC FASCIITIS; FREQUENCY ANALYSIS; HUMAN; HYPEREOSINOPHILIA; HYPOCOMPLEMENTEMIA; MEDLINE; NECROTIZING ARTERITIS; PERIPHERAL CIRCULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; SKIN NECROSIS; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; TREATMENT INDICATION; WEGENER GRANULOMATOSIS;

EID: 15044356696     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0468-7     Document Type: Review

References (40)

1. Rothenberg ME (1998) Mechanisms of disease: eosinophilia. N Engl J Med 338:1592
2. Takatsu K, Tominaga A, Harada N, Mita S, Matsumoto M, Takahashi T, Kikuchi Y, Yamaguchi N (1988) T cell-replacing factor (TRF)/interleukin 5 (IL-5): molecular and functional properties. Immunol Rev 102:107
3. Galli SJ, Gordon JR, Wershil BK (1994) Mast cell and eosinophil cytokines in allergy and inflammation. In: Kay AB, Gleich GJ (eds) Eosinophils in allergy and inflammation, vol 2. Clinical allergy and immunology. Dekker, New York, pp 255-280
4. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE (1989) Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64
5. Palacios R, Karasuyama H, Rolink A (1987) Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J 6:3687
6. Takatsu K, Yamaguchi N, Hitoshi Y, Sonoda E, Mita S, Tominaga A (1989) Signal transduction through interleukin-5 receptors. Cold Spring Harb Symp Quant Biol 2:745
7. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K (1988) Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167:43
8. Sanderson CJ (1990) Eosinophil differentiation factor (interleukin-5). Immunol Ser 49:231
9. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman RJ, Austan KF J (1989) Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343
10. Owen W Jr, Petersen J, Sheff DM et al (1990) Hypodense eosinophils and interleukin 5 activity in the blood of patients with the eosinophilia-myalgia syndrome. Proc Natl Acad Sci U S A 87:8647-8651
11. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101
12. Rytomaa T (1960) Organ distribution and histochemical properties of eosinophil granulocytes in the rat. Act Pathol Microbiol Scand 50:1
13. Barth H, Berg PA, Klein R (1999) Is there any relationship between eosinophilia myalgia syndrome and fibromyalgia syndrome? An analysis of clinical and immunologic data, tryptophan, seratonin and melatonin. Basic Aspects and Applications 61:487-496
14. Klein P, Berg PA (1994) A comperative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Clin Invest 72:451-459
15. Kargili A, Bavbek N, Kaya A, Kosar A, Karaaslan Y (2003) Eosinophilia in rheumatologic diseases. Rheumatol Int (in press)
16. Murray JK, Laxer RM (2002) Scleroderma in children and adolescents. Rheum Dis Clin North Am 28:603-624
17. Bodemer C, Belon M, Hamel-Teillac D, Amoric JC, Fraitag S, Prieur AM, De Prost Y (1999) Scleroderma in children: a retrospective study of 70 cases. Ann Dermatol Venereol 26:691-694
18. Falanga V, Medsger TA Jr (1987) Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol 17:648-656
19. Van de Laar MJ, van der Korst JK (1991) Rheumatoid arthritis, food, and allergy. Semin Arthr Rheum 21:12-23
20. Fox R, van Breemen J (1934) Chronic rheumatism: causation and treatment. Churchill, London, p 155
21. Short CL, Bauer W, Reynolds WE (1957) Rheumatoid arthritis. Harvard University Press, Cambridge, pp 354-356
22. Sylvester RA, Pinals RS (1970) Eosinophilia in rheumatoid arthritis. Ann Allergy 45:234-247
23. Davis P, Hughes GRV (1974) Significance of eosinophilia during gold therapy. Arthritis Rheum 17:964-968
24. Jessop JD, Dippy J, Turnbull A, Bright M (1974) Eosinophilia during gold therapy. Rheumatol Rehab 13:75-79
25. Kay AGL (1976) Myelotoxicity of gold. Br Med J 1:1266-1268
26. Andres MC, Hidalgo C, Balsa A, Castro M, Fernandez DE (1973) Eosinophilia in rheumatoid arthritis masked by eosinophil peroxidase deficiency. Clin Lab Haemat 15:67-73
27. Smith DH, Scott DL, Zaphiropoulas GC (1983) Eosinophilia in D-penicillamine therapy. Ann Rheum Dis 42:408-410
28. Jaffe IA (1965) The effect of penicillamine on laboratory parameters in rheumatoid arthritis, Arthritis Rheum 8:1064-1079
29. Kishimoto N, Fujii K (2002) A case of pulmonary infiltration with eosinophilia (PIE) syndrome induced by bucillamine treatment of rheumatoid arthritis. Nihon Kokyuki Gakkai Zasshi 40:321-325
30. Savolainen HA, Leirisalo-Repo M (2001) Eosinophilia as a side-effect of methotrexate in patients with chronic arthritis. Clin Rheumatol 20:432-434
31. Schwake L, Stremmel W, Sergi C (2002) Eosinophilic enterocolitis in a patient with rheumatoid arthritis. J Clin Gastroenterol 34:487-495
32. Medina PM, Novales VG, Medina PA et al (1997) Eosinophilic gastroenteritis associated with rhematoid arthritis: its presentation as acute abdominal pain. Rev Esp Enferm Dig 89:143-144
33. Schwartz RH (1996) Models of T cell anergy: is there a common molecular mechanism? J Exp Med 184:1-8
34. Lie JT, Michet CJ Jr (1988) Thromboangiitis obliterans with eosinophilia (Buerger's disease) of the temporal arteries. Hum Pathol 19:598
35. Yousem SA, Lombard CM (1988) The eosinophilic variant of Wegener's granulomatosis. Hum Pathol 19:682
36. Krupsky M, Landau Z, Lifschitz-Mercer B, Resnitzky P (1993) Wegener's granulomatosis with peripheral eosinophilia: atypical variant of a classic disease. Chest 104:1290
37. Chan YC, Tay YK, Ng SK (2002) Allopurinol hypersensitivity syndrome and acute myocardial infarction two case reports. Ann Acad Med Singapore 31:231-233
38. Khoo BP, Leow YH (2000) A review of inpatients with adverse drug reactions to allopurinol. Singapore Med J 41:156-160
39. Pluim HJ, van Deuren M, Wetzels JF (1998) The allopurinol hypersensitivity syndrome. Neth J Med 52:107-110
40. Singer JZ, Wallace SL (1986) The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 29:82-87